Form 4 for ISRG Intuitive Surgical
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-12 · accession 0001035267-24-000265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-13 | 2024-11-12 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $197.39 | +13.5K | 4,308 | New | +$2.66M |
| DM | 2024-11-13 | 2024-11-12 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $535.96 | -13.5K | 298 | -98% | -$7.22M |
| DM | 2024-11-13 | 2024-11-12 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -13.5K | 2,829 | -83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-12 | M | A | 2,199 | $229.39 | 2,497 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-12 | S | D | 2,199 | $535.96 | 298 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-11-12 | S | D | 4,010 | $535.96 | 298 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-11-12 | S | D | 2,257 | $535.96 | 298 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-11-12 | M | A | 2,257 | $177.99 | 2,555 | D | — | — | |
| 6 | Common | Common Stock | 2024-11-12 | S | D | 5,000 | $535.96 | 298 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2024-11-12 | M | A | 5,000 | $182.83 | 5,298 | D | — | — | |
| 8 | Common | Common Stock | 2024-11-12 | M | A | 4,010 | $208.90 | 4,308 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-11-12 | M | D | 4,010 | $0.00 | 2,005 | D | $208.90 · — to 2029-08-28 | 4,010 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-11-12 | M | D | 5,000 | $0.00 | 0 | D | $182.83 · — to 2029-02-15 | 5,000 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-11-12 | M | D | 2,257 | $0.00 | 0 | D | $177.99 · — to 2030-02-28 | 2,257 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-11-12 | M | D | 2,199 | $0.00 | 2,829 | D | $229.39 · — to 2030-02-27 | 2,199 Common Stock | (F5) 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |